In addition, silencing of JAK1 in a variety of tumor cell types, or treatment of these cells with JAK inhibitors, induced increased secretion of IFNγ by co-cultured NK cells and enhanced susceptibility of the tumor cells to NK-mediated lysis [86]. This evidence concerns the gene JAK1 and neoplasm.